| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 03/10/2004 | EP1395599A1 Anti-tumour anthracycline glycoside 14-sulfonic acid derivatives |
| 03/10/2004 | EP1395596A2 Methods for preparation and use of psorospermin analogs |
| 03/10/2004 | EP1395591A1 Corticotropin releasing factor antagonists |
| 03/10/2004 | EP1395590A2 Dihydropyrrolo[1,2-a]indole and tetrahydropyrido[1,2-a]indole derivatives as prostaglandin d2 receptor antagonists |
| 03/10/2004 | EP1395585A1 Antibacterial agents |
| 03/10/2004 | EP1395583A1 New phenylpiperazines |
| 03/10/2004 | EP1395582A1 Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same |
| 03/10/2004 | EP1395581A2 Novel benzothienyl or indole derivatives, preparation and use thereof as inhibitors of prenyl transferase proteins |
| 03/10/2004 | EP1395576A1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 03/10/2004 | EP1395575A1 4-(penyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 03/10/2004 | EP1395574A1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 03/10/2004 | EP1395571A1 Compounds and methods for the treatment or prevention of flavivirus infections |
| 03/10/2004 | EP1395568A1 4-aminopyrimidine derivatives |
| 03/10/2004 | EP1395566A1 Tricyclic compounds useful as angiotensin ii agonists |
| 03/10/2004 | EP1395563A1 2-substituted 1,2,3,4-tetrahydroquinolines and derivatives thereof, compositions and methods |
| 03/10/2004 | EP1395562A1 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl- 2,3']bipyridinyl in pure crystalline form and process for synthesis |
| 03/10/2004 | EP1395559A1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain anxiety or gastrointestinal disorders |
| 03/10/2004 | EP1395557A1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 03/10/2004 | EP1395554A1 Substituted carbazoles as inhibitors of spla2 |
| 03/10/2004 | EP1395553A1 Pyrrolidine derivatives as factor xa inhibitors |
| 03/10/2004 | EP1395551A2 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer's disease and similar diseases |
| 03/10/2004 | EP1395550A1 Cycloalkenylsulfonamide derivatives |
| 03/10/2004 | EP1395305A1 Using supercritical fluids to infuse therapeutic on a medical device |
| 03/10/2004 | EP1395285A2 Reagents and methods for modulating dkk-mediated interactions |
| 03/10/2004 | EP1395284A2 Cd4-specific antibody trx1 and uses therefor |
| 03/10/2004 | EP1395278A2 Ocular tear growth factor-like protein |
| 03/10/2004 | EP1395277A1 The use of a gatran for the manufacture of a medicament for the treatment of pulmonary fibrosis |
| 03/10/2004 | EP1395271A1 Herbal compositions for the treatment of mucosal lesions |
| 03/10/2004 | EP1395270A1 Use of phyllanthus constituents for treating or preventing infections caused by hepatit |
| 03/10/2004 | EP1395268A1 A method of implanting heavy metal such as nobel metal, e.g. gold, and metal for use in implantation |
| 03/10/2004 | EP1395265A2 Combretastatin a-3 prodrug |
| 03/10/2004 | EP1395263A1 3, 7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents for lowering intraocular pressure |
| 03/10/2004 | EP1395259A2 Urazole compounds useful as anti-inflammatory agents |
| 03/10/2004 | EP1395257A1 Macrocycles useful in the treatment of alzheimer's disease |
| 03/10/2004 | EP1395256A2 Prodrugs via acylation with cinnamate |
| 03/10/2004 | EP1395251A2 Aminediols as agents for the treatment of alzheimer's disease |
| 03/10/2004 | EP1395244A1 Oxidized collagen formulations for use with non-compatible pharmaceutical agents |
| 03/10/2004 | EP1395215A1 Quinolone carboxylic acid compositions and related methods of treatment |
| 03/10/2004 | EP1303249B1 Antimycotic nail varnish composition |
| 03/10/2004 | EP1236725B1 Novel 1,8-naphthyridin-2(1h)-one derivatives |
| 03/10/2004 | EP1112275B9 Novel heteroaromatic inhibitors of fructose 1,6-bisphosphatase |
| 03/10/2004 | EP1087769B1 Use of a pyridazinone derivative as calcium sensitizer |
| 03/10/2004 | EP1054673B1 Benzoxazine compounds for enhancing synaptic response |
| 03/10/2004 | EP0957911B1 HESPERIDIN AND HESPERETIN AS 3-HYDROXY-3-METHYLGLUTARYL CoA(HMG-CoA) REDUCTASE INHIBITOR |
| 03/10/2004 | EP0885011B1 Diagnosis of autoimmune diseases of the inner ear based on the detection of myelin protein p zero |
| 03/10/2004 | EP0804435B1 Novel imidazole derivatives, method for preparing same, novel intermediates thus obtained, medicinal applications of same and pharmaceutical compositions containing same |
| 03/10/2004 | CN1481390A Immunomodulatory peptidesderived from heat shock proteins and uses thereof |
| 03/10/2004 | CN1481388A 14(15)-unsturated 15-and/or 16-substituted androgens with mixed androgen-progestational profile |
| 03/10/2004 | CN1481383A Method for producing anticholinergic agent tiotropium bromide |
| 03/10/2004 | CN1481382A Isoindolin-1-one glucokinase activators |
| 03/10/2004 | CN1481381A Diphenyl azetidinone derivatives, method for prodn. thereof medicaments contg. these compounds, and their use |
| 03/10/2004 | CN1481380A Novel benzazepines and related heterocyclic derivatives which are useful as orexin receptor antagonists |
| 03/10/2004 | CN1481379A Substituted pyrrolidines as CCR-3 receptor antagonists |
| 03/10/2004 | CN1481377A Cyclic Beta-amino acid derivatives as inhibitors of matrix metalloproteases and TNF alhpa |
| 03/10/2004 | CN1481376A Oxybenzamides derivatives as factor xa inhibitors |
| 03/10/2004 | CN1481373A 1,5-benzothiazepines compounds and its use as antilipemic agent |
| 03/10/2004 | CN1481372A 1,1-dioxo-2H-1,2-benzothiazine-3-carboxamide derivatives, method for preparing same and pharmaceutical compsns comprising same |
| 03/10/2004 | CN1481370A Quinazoline derivatives, medicaments contg. said compounds, their utilization and method for prodn. thereof |
| 03/10/2004 | CN1481368A Gyrase imhibitors and uses thereof |
| 03/10/2004 | CN1481367A Imidazole and benzimiddzole caspase inhibitors and uses thereof |
| 03/10/2004 | CN1481366A Dihydroindole and tetrahydroquinoline derivatives |
| 03/10/2004 | CN1481364A Urea and urethane derivatives as integrin inhibitors |
| 03/10/2004 | CN1481360A 蕈毒碱拮抗剂 Muscarinic antagonist |
| 03/10/2004 | CN1481253A Drugs and foods improving quality of life and process for producng same |
| 03/10/2004 | CN1481251A Combined method for treating viral infections |
| 03/10/2004 | CN1481243A Pharmaceutical formulation contg. thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives (2) |
| 03/10/2004 | CN1481242A Pharmaceutical formulation contg thienopyrimidines and antithrombotics, calcium-antagonists, prostaglandins or prostaglandin derivatives |
| 03/10/2004 | CN1481241A Therapeutic combination of amlodipine and benazepril/benazeprilat |
| 03/10/2004 | CN1481240A Antilipemic agents |
| 03/10/2004 | CN1481238A Aniline derivatives or salts thereof and cytokine prodn inhibitors contg. same |
| 03/10/2004 | CN1480217A Medicinal preparation and its prepn. and application |
| 03/10/2004 | CN1480207A Spore of gandoderma lucidum for treating disease of autoimmunity |
| 03/10/2004 | CN1480206A Combination of gadol and Chinese caterpillar fungus as well as preparing method |
| 03/10/2004 | CN1480157A Preparation capable of promoting growth and intelligence development for teenagers and children as well as its preparing method |
| 03/10/2004 | CN1480139A Local medical compsn contg cholinergic medicine or calcium passage retardant |
| 03/10/2004 | CN1480138A Colored soft eapsule preparation of nimodipine and its preparing method |
| 03/10/2004 | CN1141297C Process for preparing amlodiping benzenesulphonate |
| 03/10/2004 | CN1141295C Indoline derivatives as progesterohe antagonists |
| 03/10/2004 | CN1141118C Prepn method for hualu health nutritive article |
| 03/10/2004 | CN1141091C Application of full-trans-tretinoin in preparing medicines to cure myocardial hypertrophy and vessel wall hyperplasia |
| 03/10/2004 | CN1141089C Antimicrobials |
| 03/09/2004 | US6703502 Spiroazo bicyclic heterocyclic |
| 03/09/2004 | US6703486 Peripheral nervous system specific sodium channels |
| 03/09/2004 | US6703425 Sulfonamide derivatives |
| 03/09/2004 | US6703423 For therapy of polymorphoneutrophil (pmn) inflammation |
| 03/09/2004 | US6703422 For therapy and prophylaxis of cardiovascular disease, dyslipidemia; dyslipoproteinemia; disorder of glucose metabolism; alzheimer's disease; syndrome x; peroxisome proliferator activated receptor-associated disorder |
| 03/09/2004 | US6703417 Improved bioavailability; anticarcinogenic |
| 03/09/2004 | US6703413 Production of apoptotic films for direct contact with tumors |
| 03/09/2004 | US6703404 Nitric oxide synthase inhibitors |
| 03/09/2004 | US6703399 Halo-alkyl esters of camptothecins and methods of treating cancer using these compounds |
| 03/09/2004 | US6703393 Treatment of a variety of central nervous system (cns) disorders in humans, domesticated companion animals and livestock animals. treatment of anxiety, depression, a sleep disorder, attention deficit disorder, or alzheimer's dementia, |
| 03/09/2004 | US6703392 Orexin receptor antagonists for obesity or sleeping disorder treatment |
| 03/09/2004 | US6703389 Optically pure reboxetine or its methanesulfonate salt inhibits reuptake of norepinephrine |
| 03/09/2004 | US6703387 Inhibitors of HPV E1 helicase enzyme |
| 03/09/2004 | US6703381 Administering amphiphilic enkephalin-oligomer conjugate |
| 03/09/2004 | US6703368 Peptide-containing α-ketoamide cysteine and serine protease inhibitors |
| 03/09/2004 | US6703365 Glucagon-like insulinotropic peptides, compositions and methods |
| 03/09/2004 | US6703215 Detecting preferential enzyme inhibitor; obtain substrate, incubate with enzyme mixture, expose to enzyme inhibitor, monitor for decrease in enzymatic activity |
| 03/09/2004 | US6703046 Highly cross-linked, extremely hydrophobic nitric oxide-releasing polymers and methods for their manufacture and use |
| 03/09/2004 | US6702839 Method of controlling body temperature while reducing shivering |